Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023
Tue, October 10, 2023
Mon, October 9, 2023

Luca Issi Maintained (ALNY) at Buy with Decreased Target to $235 on, Oct 11th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-235-on-oct-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Luca Issi of RBC Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $270 to $235 on, Oct 11th, 2023.

Luca has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $175 on, Tuesday, October 10th, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023


These are the ratings of the 6 analyists that currently disagree with Luca


  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023